Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2007;27:2476-2483
Published online before print August 30, 2007, doi: 10.1161/ATVBAHA.107.150698
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
27/11/2476    most recent
ATVBAHA.107.150698v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Korporaal, S. J.A.
Right arrow Articles by Akkerman, J.-W. N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Korporaal, S. J.A.
Right arrow Articles by Akkerman, J.-W. N.
Related Collections
Right arrow Signal transduction
Right arrow Lipid and lipoprotein metabolism
Right arrow Platelets
Right arrow Cell signalling/signal transduction
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2007;27:2476.)
© 2007 American Heart Association, Inc.


Thrombosis

Platelet Activation by Oxidized Low Density Lipoprotein Is Mediated by Cd36 and Scavenger Receptor-A

Suzanne J.A. Korporaal; Miranda Van Eck; Jelle Adelmeijer; Martin Ijsseldijk; Ruud Out; Ton Lisman; Peter J. Lenting; Theo J.C. Van Berkel; Jan-Willem N. Akkerman

From the Department of Clinical Chemistry and Haematology (S.J.A.K., J.A., M.I., T.L., P.J.L., J.-W.N.A.), University Medical Center Utrecht, and Institute of Biomembranes, Utrecht University, the Netherlands; and the Division of Biopharmaceutics (S.J.A.K., M.V.E., R.O., T.J.C.V.B.), Leiden/Amsterdam Center for Drug Research, Gorlaeus Laboratories, Leiden University, the Netherlands.

Correspondence to Prof Dr J.W.N. Akkerman, Department of Clinical Chemistry and Haematology (G03.550), University Medical Center Utrecht, P.O. Box 85500, 3508 GA Utrecht, the Netherlands. E-mail j.w.n.akkerman{at}umcutrecht.nl

Objective— The interaction of platelets with low density lipoprotein (LDL) contributes to the development of cardiovascular disease. Platelets are activated by native LDL (nLDL) through apoE Receptor 2' (apoER2')-mediated signaling to p38MAPK and by oxidized LDL (oxLDL) through lysophosphatidic acid (LPA) signaling to Rho A and Ca2+. Here we report a new mechanism for platelet activation by oxLDL.

Methods and Results— Oxidation of nLDL increases p38MAPK activation through a mechanism that is (1) independent of LPA, and (2) unlike nLDL-signaling not desensitized by prolonged platelet-LDL contact or inhibited by receptor-associated protein or chondroitinase ABC. Antibodies against scavenger receptors CD36 and SR-A alone fail to block p38MAPK activation by oxLDL but combined blockade inhibits p38MAPK by >40% and platelet adhesion to fibrinogen under flow by >60%. Mouse platelets deficient in either CD36 or SR-A show normal p38MAPK activation by oxLDL but combined deficiency of CD36 and SR-A disrupts oxLDL-induced activation of p38MAPK by >70%.

Conclusion— These findings reveal a novel platelet-activating pathway stimulated by oxLDL that is initiated by the combined action of CD36 and SR-A.

Platelets are activated by nLDL through binding to apoER2', which signals to p38MAPK. Oxidation induces more p38MAPK activation through loss of apoER2' binding thereby initiating the combined activity of CD36 and SR-A.


Key Words: platelets • LDL • oxidized LDL • CD36 • scavenger receptor-A




This article has been cited by other articles:


Home page
Circ. Res.Home page
K. Chen, M. Febbraio, W. Li, and R. L. Silverstein
A Specific CD36-Dependent Signaling Pathway Is Required for Platelet Activation by Oxidized Low-Density Lipoprotein
Circ. Res., June 20, 2008; 102(12): 1512 - 1519.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. Siegel-Axel, K. Daub, P. Seizer, S. Lindemann, and M. Gawaz
Platelet lipoprotein interplay: trigger of foam cell formation and driver of atherosclerosis
Cardiovasc Res, April 1, 2008; 78(1): 8 - 17.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Collot-Teixeira, F. Delorenzo, and J. L. McGregor
Scavenger Receptor A and CD36 Are Implicated in Mediating Platelet Activation Induced by Oxidized Low- Density Lipoproteins
Arterioscler. Thromb. Vasc. Biol., December 1, 2007; 27(12): 2491 - 2492.
[Full Text] [PDF]